Estimating autoantibody signatures to detect autoimmune disease patient subsets

Zhenke Wu, Livia Casciola‐Rosen, Ami A. Shah, Antony Rosen, Scott L. Zeger

TL;DR

Researchers have developed a novel Bayesian hierarchical model to "dewarp" and align noisy gel electrophoresis images, enabling the discovery of distinct autoantibody signatures in autoimmune patients. By correcting for physical distortions and experimental "batch effects," this method significantly improves the accuracy of patient subsetting, turning messy biological data into clear, actionable clinical clusters.

What Problem Does This Paper Address?

In autoimmune diseases, the body’s immune system mistakenly attacks self-tissues, producing specific proteins called autoantibodies. These antibodies serve as "molecular fingerprints" that can help doctors diagnose specific disease subsets and predict patient outcomes.

A common tool for finding these fingerprints is Gel Electrophoresis and Autoradiography (GEA). In GEA, proteins are separated by weight on a gel, creating a pattern of bands. However, GEA is notoriously "messy." Gels can warp due to heat, proteins might migrate at slightly different speeds across different experiments (batch effects), and irrelevant intensity differences can obscure real patterns. Traditionally, experts try to read these patterns by eye, but as datasets grow, human recognition fails to scale and lacks reproducibility. This paper tackles the challenge of automating the "cleaning" and alignment of this data so that standard clustering algorithms can actually work.

Methods

The authors propose a two-stage statistical pipeline to pre-process GEA data:

  1. Peak Detection: They use a "local difference scoring" algorithm. Instead of looking at absolute intensity, it looks at the shape of the peaks relative to their neighbors. This makes the method robust against background noise and overall brightness differences.
  2. Bayesian Spatial Dewarping: This is the core innovation. The model treats the physical warping of the gel as a mathematical function that needs to be "undone."
    • Reference Alignment: First, they use known "landmark" proteins (markers of known weight) to perform a rough piecewise linear alignment.
  3. Hierarchical Bayesian Model: They use cubic B-splines to model the non-linear warping across the gel. Crucially, they use shrinkage priors. This allows the model to "borrow strength" across different lanes; if a common protein (like actin) appears in many samples, the model uses its position to help align all the other lanes more accurately.
  4. Uncertainty Quantification: Unlike standard "best-fit" methods, the Bayesian approach provides a posterior distribution, giving researchers a measure of how confident the model is in its alignment.

Datasets

The methods were evaluated using two primary datasets involving patients with Scleroderma (a chronic connective tissue disease):

  • Replication Dataset: 20 biological samples, each run twice (long vs. short exposure) to create 20 replicate pairs (40 lanes total). This served as a "ground truth" to see if the model could correctly pair the replicates.
  • Discovery Dataset: 76 scleroderma patients with unknown clustering, used to demonstrate the model's ability to find scientifically meaningful subgroups in a real-world clinical setting.

Key Insights and Ideas

  • The "Actin" Anchor: The researchers realized that certain proteins, like actin, are ubiquitous. By treating these as "universal landmarks" within the Bayesian framework, they can align disparate gel images even when the rest of the autoantibody signatures are highly variable.
  • Sign over Magnitude: In peak detection, the sign of the difference between adjacent bins is more important than the absolute intensity. This "local scoring" prevents high-intensity "blobs" from drowning out smaller, but clinically relevant, peaks.
  • Warping is Smooth: The model assumes that gel deformation is spatially smooth. By enforcing this through B-spline constraints, the model avoids "over-fitting" to random noise while still capturing the complex "S-shaped" or "7-shaped" distortions common in electrophoresis.

Key Results

  • Better Clustering: In the replication study, pre-processing significantly increased the Adjusted Rand Index (aRI), meaning the algorithm was much better at correctly identifying replicate pairs compared to using raw data.
  • Increased Confidence: The "average silhouette" (a measure of how tightly grouped and well-separated clusters are) increased by 14% to 118% after dewarping.
  • Discovery of Subsets: In the 76-patient study, the model identified a cluster of seven patients with a specific signature (enriched at 32.7 and 27.9 kDa) that was completely missed or split apart by standard analysis without dewarping.

Limitations and Future Work

The authors acknowledge a few areas for improvement:

  • Tuning Parameters: The peak detection currently relies on a manually set tuning parameter ($h$) for locality; future versions could benefit from automated selection.
  • Biological Complexes: Currently, the model treats each protein band as independent. However, proteins often work in complexes. The authors suggest a future "Bayesian factorization" approach to identify groups of bands that always appear together, which would represent a single multi-protein target.
  • Covariates: The model doesn't yet incorporate patient metadata (like age or cancer status) directly into the alignment process, which could further refine the discovery of disease-specific signatures.

Summary updated

Abstract

Autoimmune diseases are characterized by highly specific immune responses against molecules in self-tissues. Different autoimmune diseases are characterized by distinct immune responses, making autoantibodies useful for diagnosis and prediction. In many diseases, the targets of autoantibodies are incompletely defined. Although the technologies for autoantibody discovery have advanced dramatically over the past decade, each of these techniques generates hundreds of possibilities, which are onerous and expensive to validate. We set out to establish a method to greatly simplify autoantibody discovery, using a pre-filtering step to define subgroups with similar specificities based on migration of radiolabeled, immunoprecipitated proteins on sodium dodecyl sulfate (SDS) gels and autoradiography [Gel Electrophoresis and band detection on Autoradiograms (GEA)]. Human recognition of patterns is not optimal when the patterns are complex or scattered across many samples. Multiple sources of errors-including irrelevant intensity differences and warping of gels-have challenged automation of pattern discovery from autoradiograms.In this article, we address these limitations using a Bayesian hierarchical model with shrinkage priors for pattern alignment and spatial dewarping. The Bayesian model combines information from multiple gel sets and corrects spatial warping for coherent estimation of autoantibody signatures defined by presence or absence of a grid of landmark proteins. We show the pre-processing creates more clearly separated clusters and improves the accuracy of autoantibody subset detection via hierarchical clustering. Finally, we demonstrate the utility of the proposed methods with GEA data from scleroderma patients.
BibTeX
@inproceedings{wu2017estimating,
  author = {Zhenke Wu and Livia Casciola‐Rosen and Ami A. Shah and Antony Rosen and Scott L. Zeger},
  title = {{Estimating autoantibody signatures to detect autoimmune disease patient subsets}},
  booktitle = {Biostatistics},
  year = {2017},
  doi = {10.1093/biostatistics/kxx061},
}

Loading related content...

Figure